查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595253

兒科疫苗市場：按技術、疫苗、適應症和最終用戶分類 - 全球預測 2025-2030

Pediatric Vaccines Market by Technology (Attenuated Live Viruses, Conjugates, Inactivated Viruses), Vaccine (Monovalent, Multivalent), Indication, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年兒科疫苗市場規模為190.7億美元，預計2024年將達212.6億美元，複合年成長率為11.57%，2030年將達410.6億美元。

兒科疫苗市場是一個廣泛的市場，涵蓋了從嬰幼兒到青春期兒童的免疫需求。現代兒科疫苗旨在預防多種感染疾病，包括麻疹、德國麻疹、脊髓灰質炎、小兒麻痺、流感和水痘。實現群體免疫和預防疫情的目標強調了對這些疫苗的需求。這些疫苗用於公共和私人醫療機構，包括診所、醫院和藥房疫苗接種中心，用於常規免疫計劃和特殊免疫宣傳活動。

主要市場統計
基準年[2023] 190.7億美元
預測年份 [2024] 212.6億美元
預測年份 [2030] 410.6億美元
複合年成長率（%） 11.57%

該市場的主要推動力是人們對疫苗接種益處的認知不斷提高、政府的強制要求以及世界衛生組織和聯合國兒童基金會等組織的全球衛生計劃。疫苗技術的進步、官民合作關係以及兒童傳染病發病率的上升也起到了幫助作用。此外，用於開發新型疫苗的研發投資正在增加，尤其是 mRNA 技術的出現提供了利潤豐厚的機會。然而，市場成長受到疫苗猶豫、供應鏈中斷、市場開拓高成本以及阻礙新疫苗推出的嚴格監管要求的阻礙。

為了抓住潛在的機會，企業應專注於給藥方法的創新，例如無針技術，並尋求擴大疫苗保護範圍。專注於數位健康整合將有助於提高疫苗追蹤和疫苗接種效率。可以透過制定有效的傳播策略來應對挑戰和反制錯誤訊息，並建立夥伴關係以擴大新興市場的准入，從而促進市場擴張。繼續研究聯合疫苗和改善低溫運輸物流是業務成長的關鍵領域。市場動態是動態的，其特點是技術快速發展、監管監督和業務複雜性，但為成功應對這些挑戰的公司提供了巨大的創新和擴張潛力。

市場動態：揭示快速發展的兒科疫苗市場的關鍵市場洞察

供需的動態交互作用正在改變兒科疫苗市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 兒科族群感染疾病率不斷上升
    • 疫苗接種的好處，例如預防嚴重和防止感染他人
    • 政府介入兒童疫苗的使用
  • 市場限制因素
    • 缺乏強制疫苗接種
    • 與兒童疫苗相關的輕微副作用
  • 市場機會
    • 強大的後期研發管線和新藥認證
    • 嬰幼兒定期接種疫苗
  • 市場挑戰
    • 沒有統一的召回或提醒系統，缺乏人員

波特五力：駕馭兒科疫苗市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解兒科疫苗市場的外部影響

外部宏觀環境因素在塑造兒科疫苗市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解兒科疫苗市場的競爭格局

對兒科疫苗市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣兒科疫苗市場供應商的績效評估

FPNV定位矩陣是評估兒科疫苗市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製兒科疫苗市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對兒科疫苗市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 兒科人群感染疾病率增加
      • 疫苗接種的好處包括預防嚴重疾病和預防疾病傳播給他人。
      • 政府介入兒童疫苗的使用
    • 抑制因素
      • 強制疫苗接種落實不到位
      • 與兒童疫苗相關的輕微副作用
    • 機會
      • 強大的後期研發管線和新藥認證
      • 用於嬰幼兒免疫接種的常規疫苗
    • 任務
      • 沒有統一的召回或提醒系統，人員配備不足
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章兒科疫苗市場：依技術分類

  • 減毒活病毒
  • 共軛形式
  • 去活化病毒
  • 多醣
  • 重組
  • 次單元
  • 類毒素

第7章 兒科疫苗市場疫苗

  • 單價
  • 多效價的

第8章以適應症分類的兒科疫苗市場

  • B型流感嗜血桿菌
  • 肝炎
  • 人類乳突病毒
  • 麻疹
  • 甲型腦膜炎
  • 腮腺炎
  • 肺炎鏈球菌感染
  • 脊髓灰質炎
  • 輪狀病毒
  • 德國麻疹
  • 破傷風
  • 黃熱病

第9章兒科疫苗市場：依最終用戶分類

  • 醫院
  • 小兒科診所
  • 研究機構

第10章美洲兒科疫苗市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區兒科疫苗市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲兒科疫苗市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AstraZeneca PLC
  • Bavarian Nordic A/S
  • CSL Limited
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Indian Immunologicals Ltd.
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mitsubishi Chemical Corporation
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • SINOVAC Biotech Ltd.
  • Zoetis Inc.
Product Code: MRR-030EE4851566

The Pediatric Vaccines Market was valued at USD 19.07 billion in 2023, expected to reach USD 21.26 billion in 2024, and is projected to grow at a CAGR of 11.57%, to USD 41.06 billion by 2030.

The pediatric vaccines market encompasses a broad scope, targeting the immunization needs of children from infancy through adolescence. Modern pediatric vaccines are designed to protect against a variety of infectious diseases, including measles, mumps, rubella, polio, influenza, and chickenpox, among others. The necessity of these vaccines is underscored by the objective of achieving herd immunity and preventing outbreaks, which is critical for public health. They find applications in public and private healthcare settings, including clinics, hospitals, and pharmacy-based immunization centers, catering to both routine immunization schedules and special vaccination campaigns.

KEY MARKET STATISTICS
Base Year [2023] USD 19.07 billion
Estimated Year [2024] USD 21.26 billion
Forecast Year [2030] USD 41.06 billion
CAGR (%) 11.57%

The market is primarily driven by increased awareness of the benefits of immunization, government mandates, and global health initiatives from organizations such as WHO and UNICEF. Boosting factors include advancements in vaccine technology, public-private partnerships, and rising incidence of contagious diseases in children. Additionally, growing investments in R&D efforts for novel vaccine development provide lucrative opportunities, especially with the emergence of mRNA technologies. However, market growth is challenged by vaccine hesitancy, supply chain disruptions, high costs of development, and stringent regulatory requirements, which can impede the introduction of new vaccines.

To seize potential opportunities, companies should focus on innovations in delivery methods, such as needle-free technologies, and explore the extension of vaccine protection durations. Emphasizing digital health integration can help enhance vaccine tracking and coverage efficiency. Addressing challenges, fostering effective communication strategies to combat misinformation, and fostering collaborations for expanding access in emerging markets can facilitate market expansion. Continued research into combination vaccines and better cold chain logistics are pivotal areas for business growth. The pediatric vaccines market is dynamic, characterized by rapid technological evolution, regulatory scrutiny, and operational complexities, yet it offers vast potential for innovation and expansion for firms that navigate these challenges adeptly.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pediatric Vaccines Market

The Pediatric Vaccines Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of infectious diseases in the pediatric population
    • Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
    • Government intervention for the use of pediatric vaccines
  • Market Restraints
    • Lack of implementation of mandatory vaccination
    • Slight-side effects associated with pediatric vaccines
  • Market Opportunities
    • Strong late-stage pipeline and new drug approvals
    • Routinized vaccines used in immunization of infants and children
  • Market Challenges
    • No uniform recall or reminder system and staff shortages

Porter's Five Forces: A Strategic Tool for Navigating the Pediatric Vaccines Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pediatric Vaccines Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pediatric Vaccines Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pediatric Vaccines Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pediatric Vaccines Market

A detailed market share analysis in the Pediatric Vaccines Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pediatric Vaccines Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pediatric Vaccines Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pediatric Vaccines Market

A strategic analysis of the Pediatric Vaccines Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pediatric Vaccines Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Bavarian Nordic A/S, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Indian Immunologicals Ltd., Johnson & Johnson Services, Inc., Merck & Co., Inc., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., SINOVAC Biotech Ltd., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids.
  • Based on Vaccine, market is studied across Monovalent and Multivalent.
  • Based on Indication, market is studied across Haemophilus Influenzae Type B, Hepatitis, Human Papillomavirus , Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever.
  • Based on End User, market is studied across Hospital, Pediatric Clinic, and Research Organization.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious diseases in the pediatric population
      • 5.1.1.2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
      • 5.1.1.3. Government intervention for the use of pediatric vaccines
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of implementation of mandatory vaccination
      • 5.1.2.2. Slight-side effects associated with pediatric vaccines
    • 5.1.3. Opportunities
      • 5.1.3.1. Strong late-stage pipeline and new drug approvals
      • 5.1.3.2. Routinized vaccines used in immunization of infants and children
    • 5.1.4. Challenges
      • 5.1.4.1. No uniform recall or reminder system and staff shortages
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pediatric Vaccines Market, by Technology

  • 6.1. Introduction
  • 6.2. Attenuated Live Viruses
  • 6.3. Conjugates
  • 6.4. Inactivated Viruses
  • 6.5. Polysaccharides
  • 6.6. Recombinant
  • 6.7. Subunits
  • 6.8. Toxoids

7. Pediatric Vaccines Market, by Vaccine

  • 7.1. Introduction
  • 7.2. Monovalent
  • 7.3. Multivalent

8. Pediatric Vaccines Market, by Indication

  • 8.1. Introduction
  • 8.2. Haemophilus Influenzae Type B
  • 8.3. Hepatitis
  • 8.4. Human Papillomavirus
  • 8.5. Measles
  • 8.6. Meningitis A
  • 8.7. Mumps
  • 8.8. Pneumococcal Diseases
  • 8.9. Polio
  • 8.10. Rotaviruses
  • 8.11. Rubella
  • 8.12. Tetanus
  • 8.13. Yellow Fever

9. Pediatric Vaccines Market, by End User

  • 9.1. Introduction
  • 9.2. Hospital
  • 9.3. Pediatric Clinic
  • 9.4. Research Organization

10. Americas Pediatric Vaccines Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pediatric Vaccines Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pediatric Vaccines Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Bavarian Nordic A/S
  • 3. CSL Limited
  • 4. Eli Lilly and Company
  • 5. GlaxoSmithKline PLC
  • 6. Indian Immunologicals Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Merck & Co., Inc.
  • 9. Mitsubishi Chemical Corporation
  • 10. Novartis AG
  • 11. Pfizer Inc.
  • 12. Sanofi S.A.
  • 13. Serum Institute of India Pvt. Ltd.
  • 14. SINOVAC Biotech Ltd.
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. PEDIATRIC VACCINES MARKET RESEARCH PROCESS
  • FIGURE 2. PEDIATRIC VACCINES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PEDIATRIC VACCINES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PEDIATRIC VACCINES MARKET DYNAMICS
  • TABLE 7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. VIETNAM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. DENMARK PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. EGYPT PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. FINLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. ISRAEL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. NIGERIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 158. NORWAY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. POLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. SWEDEN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. SWITZERLAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TURKEY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. PEDIATRIC VACCINES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 204. PEDIATRIC VACCINES MARKET, FPNV POSITIONING MATRIX, 2023